[Therapy of lidocaine-resistant arrhythmias following experimentally severe heart infarct by supplementary sympathicolysis, especially with atenolol].
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology; D001262:Atenolol / Q000008:administration & dosage / Q000627:therapeutic use*; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004285:Dogs; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D011217:Practolol / Q000008:administration & dosage / Q000627:therapeutic use*; D011412:Propanolamines / Q000627:therapeutic use*
D011412:Propanolamines; D001262:Atenolol; D008012:Lidocaine; D011217:Practolol
Therapie Lidocain-resistenter Arrhythmien nach experimentellem schweren Herzinfarkt durch zusätzliche Sympathikolyse, speziell mit Atenolol.